Sarissa Capital Management as of Sept. 30, 2016
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 14 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ariad Pharmaceuticals | 40.5 | $176M | 13M | 13.69 | |
| Biogen Idec (BIIB) | 22.4 | $97M | 310k | 313.03 | |
| Medicines Company | 15.2 | $66M | 1.8M | 37.74 | |
| Array BioPharma | 6.7 | $29M | 4.3M | 6.75 | |
| Pacira Pharmaceuticals (PCRX) | 3.4 | $15M | 430k | 34.22 | |
| Innoviva (INVA) | 2.5 | $11M | 1.0M | 10.99 | |
| Intra Cellular Therapies (ITCI) | 2.4 | $10M | 675k | 15.24 | |
| Aegerion Pharmaceuticals | 1.8 | $7.9M | 2.6M | 2.97 | |
| Advaxis | 1.5 | $6.4M | 600k | 10.69 | |
| Apricus Bioscience | 1.1 | $4.9M | 15M | 0.34 | |
| Quest Diagnostics Incorporated (DGX) | 1.0 | $4.2M | 50k | 84.62 | |
| Vivus | 0.7 | $2.9M | 2.6M | 1.14 | |
| Abbvie (ABBV) | 0.5 | $2.0M | 32k | 63.06 | |
| AVEO Pharmaceuticals | 0.4 | $1.8M | 2.0M | 0.89 |
